Documento completo  |  Capítulo completo  |  Expandir índice  |  Versión HTML imprimible
WHO Pharmaceuticals Newsletter 2003, No. 03
(2003; 14 pages) Ver el documento en el formato PDF
Índice de contenido
Abrir esta carpeta y ver su contenidoREGULATORY MATTERS
Abrir esta carpeta y ver su contenidoSAFETY OF MEDICINES
Abrir esta carpeta y ver su contenidoCURRENT CONCERNS
Abrir esta carpeta y ver su contenidoDRUGS OF INTEREST
Abrir esta carpeta y ver su contenidoFEATURE

WHO Pharmaceuticals Newsletter 2003, No. 03


In the previous newsletter we had appealed to the Member States for greater communication on drug safety and regulatory information. We are happy to record that Bangladesh and the Republic of Maldives have responded with some recent regulatory developments in their countries. We acknowledge the Regional Adviser’s pivotal role in facilitating this information exchange.

Counterfeit medicines continue to threaten the healthcare world. Cleverly designed fake holograms of product labels and imperceptible changes to the label text make counterfeiting ever more hard to detect. In this issue, we have included an article on fake artesunate tablets, to alert readers to the level of sophistication in the world of counterfeiting.

The feature section presents an article on the workshop on pharmacovigilance that was held in Zambia in March 2003. The workshop was the first of many initiatives being planned to integrate pharmacovigilance into public health programmes.


Ir a la siguiente sección
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019